PEGO Acne Buster Salicylic Acid Drying Serum
NDC 84509-108, ZINC OXIDE,NIACINAMIDE,COLLOIDAL SULFUR,AZELAIC ACID,SALICYLIC ACID., liquid, from Guangzhou Senmai Biotechnology Co.,Ltd..
- Product NDC
- 84509-108
- Status
- Listed
- Labeler
- Guangzhou Senmai Biotechnology Co.,Ltd.
- Dosage form
- LIQUID
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M016
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/84509-108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ZINC OXIDE.2 mg/10mL
- SULFUR.03 mg/10mL
- AZELAIC ACID.024 mg/10mL
- NIACINAMIDE.05 mg/10mL
- SALICYLIC ACID.018 mg/10mL
Pharmacologic classes
Decreased Protein Synthesis [PE]; Decreased Sebaceous Gland Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 84509-108-01 | 84509010801 | 10 mL in 1 BOTTLE (84509-108-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 84509-108 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/84509-108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 84509-108. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.